Clinical Trial Update: Non-selective Beta-blocker in Compensated Advanced Chronic Liver Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for a non-selective beta-blocker in compensated advanced chronic liver disease. The study targets portal hypertension and hepatic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Decompensation
• Liver Disease
• Portal Hypertension

Drugs mentioned

• Non-selective beta-blocker

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Portal Hypertension, Hepatic Decompensation | Phase 4 | Status: RECRUITING